P27/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in Vivo

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 11, 2013, Pages 2811-2819

  Chen, Li Ching ^a   Lee, Wen Sen ^a,b  

^a School of Medicine   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

apoptosis; Magnolol; P27 Kip1; siRNA; U373

Indexed keywords

HYDROXYLATED BIPHENYLS; INDUCED APOPTOSIS; LOW CONCENTRATIONS; MAGNOLOL; P27/KIP1; SIGNALING PATHWAYS; SIRNA; U373;

CELL CULTURE; PROTEINS;

CELL DEATH;

BIPHENYL DERIVATIVE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; LIGNAN; MAGNOLOL; PLANT EXTRACT;

ANIMAL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; FEMALE; GENETICS; GLIOBLASTOMA; HUMAN; MAGNOLIA; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

ANIMALS; APOPTOSIS; BIPHENYL COMPOUNDS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; GLIOBLASTOMA; HUMANS; LIGNANS; MAGNOLIA; MALE; MICE; MICE, NUDE; PLANT EXTRACTS; SIGNAL TRANSDUCTION; UP-REGULATION;

MAGNOLIA OFFICINALIS; MAGNOLIACEAE;

EID: 84875469127     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf400542m     Document Type: Article

References (32)

1. Van Meir, E. G.; Hadjipanayis, C. G.; Norden, A. D.; Shu, H. K.; Wen, P. Y.; Olson, J. J. Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma Ca-Cancer J Clin 2010, 60, 166-193
2. Chen, L. C.; Liu, Y. C.; Liang, Y. C.; Ho, Y. S.; Lee, W. S. Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1 J. Agric. Food Chem. 2009, 57, 7331-7337
3. Ruan, J.; Zhang, L.; Yan, L.; Liu, Y.; Yue, Z.; Chen, L.; Wang, A. Y.; Chen, W.; Zheng, S.; Wang, S.; Lu, Y. Inhibition of hypoxia-induced epithelial mesenchymal transition by luteolin in non-small cell lung cancer cells Mol. Med. Rep. 2012, 6, 232-238
4. Hsu, Y. F.; Lee, T. S.; Lin, S. Y.; Hsu, S. P.; Juan, S. H.; Hsu, Y. H.; Zhong, W. B.; Lee, W. S. Involvement of Ras/Raf-1/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells Mol. Carcinog. 2007, 46, 275-283
5. Lin, S. Y.; Chang, Y. T.; Liu, J. D.; Yu, C. H.; Ho, Y. S.; Lee, Y. H.; Lee, W. S. Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells Mol. Carcinog. 2001, 32, 73-83
6. Lin, S. Y.; Liu, J. D.; Chang, H. C.; Yeh, S. D.; Lin, C. H.; Lee, W. S. Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis J. Cell. Biochem. 2002, 84, 532-544
7. Zhong, W. B.; Wang, C. Y.; Ho, K. J.; Lu, F. J.; Chang, T. C.; Lee, W. S. Magnolol induces apoptosis in human leukemia cells via cytochrome c release and caspase activation Anticancer Drugs 2003, 14, 211-217
8. Li, L. F.; Lu, J.; Li, X. M.; Xu, C. L.; Deng, J. M.; Qu, R.; Ma, S. P. Antidepressant-like effect of magnolol on BDNF up-regulation and serotonergic system activity in unpredictable chronic mild stress treated rats Phytother. Res. 2012, 26, 1189-1194
9. Tsai, T. H.; Chou, C. J.; Chen, C. F. Pharmacokinetics and brain distribution of magnolol in the rat after intravenous bolus injection J. Pharm. Pharmacol. 1996, 48, 57-59
10. Lin, Y. R.; Chen, H. H.; Ko, C. H.; Chan, M. H. Differential inhibitory effects of honokiol and magnolol on excitatory amino acid-evoked cation signals and NMDA-induced seizures Neuropharmacology 2005, 49, 542-550
11. Chen, C. R.; Tan, R.; Qu, W. M.; Wu, Z.; Wang, Y.; Urade, Y.; Huang, Z. L. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in mice Br. J. Pharmacol. 2011, 164, 1534-1546
12. Hou, Y. C.; Chao, P. D.; Chen, S. Y. Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats Am. J. Chin. Med. 2000, 28, 379-384
13. Shih, Y. L.; Liu, H. C.; Chen, C. S.; Hsu, C. H.; Pan, M. H.; Chang, H. W.; Chang, C. H.; Chen, F. C.; Ho, C. T.; Yang, Y. Y.; Ho, Y. S. Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors J. Agric. Food Chem. 2010, 58, 235-241
14. Chen, C. S.; Lee, C. H.; Hsieh, C. D.; Ho, C. T.; Pan, M. H.; Huang, C. S.; Tu, S. H.; Wang, Y. J.; Chen, L. C.; Chang, Y. J.; Wei, P. L.; Yang, Y. Y.; Wu, C. H.; Ho, Y. S. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins Breast Cancer Res. Treat. 2010, 125, 73-87
15. Oki, E.; Sakaguchi, Y.; Toh, Y.; Oda, S.; Maehara, Y.; Yamamoto, N.; Sugimachi, K. Induction of apoptosis in human tumour xenografts after oral administration of uracil and tegafur to nude mice bearing tumours Br. J. Cancer 1998, 78, 625-630
16. Ho, Y. S.; Duh, J. S.; Jeng, J. H.; Wang, Y. J.; Liang, Y. C.; Lin, C. H.; Tseng, C. J.; Yu, C. F.; Chen, R. J.; Lin, J. K. Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells Int. J. Cancer 2001, 91, 393-401
17. Griffin, R. J.; Williams, B. W.; Bischof, J. C.; Olin, M.; Johnson, G. L.; Lee, B. W. Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy Technol. Cancer Res. Treat. 2007, 6, 651-654
18. Balducci, M.; Chiesa, S.; Diletto, B.; D'Agostino, G. R.; Mangiola, A.; Manfrida, S.; Mantini, G.; Albanese, A.; Fiorentino, A.; Frascino, V.; De Bari, B.; Micciche, F.; De Rose, F.; Morganti, A. G.; Anile, C.; Valentini, V. Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: A feasibility study Neuro-Oncology 2012, 14, 79-86
19. Kawamata, N.; Morosetti, R.; Miller, C. W.; Park, D.; Spirin, K. S.; Nakamaki, T.; Takeuchi, S.; Hatta, Y.; Simpson, J.; Wilcyznski, S.; Lee, Y. Y.; Bartram, C. R.; Koeffler, H. P. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies Cancer Res. 1995, 55, 2266-2269
20. Beniston, R. G.; Campo, M. S. Quercetin elevates p27(Kip1) and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1 Oncogene 2003, 22, 5504-5514
21. Philipp, J.; Vo, K.; Gurley, K. E.; Seidel, K.; Kemp, C. J. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis Oncogene 1999, 18, 4689-4698
22. Huang, C. S.; Ho, W. L.; Lee, W. S.; Sheu, M. T.; Wang, Y. J.; Tu, S. H.; Chen, R. J.; Chu, J. S.; Chen, L. C.; Lee, C. H.; Tseng, H.; Ho, Y. S.; Wu, C. H. SP1-regulated p27/Kip1 gene expression is involved in terbinafine-induced human A431 cancer cell differentiation: an in vitro and in vivo study Biochem. Pharmacol. 2008, 75, 1783-1796
23. Hiromura, K.; Pippin, J. W.; Fero, M. L.; Roberts, J. M.; Shankland, S. J. Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1) J. Clin. Invest. 1999, 103, 597-604
24. von Kriegsheim, A.; Pitt, A.; Grindlay, G. J.; Kolch, W.; Dhillon, A. S. Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5 Nat. Cell Biol. 2006, 8, 1011-1016
25. Mason, W. P.; Belanger, K.; Nicholas, G.; Vallieres, I.; Mathieu, D.; Kavan, P.; Desjardins, A.; Omuro, A.; Reymond, D. A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression J. Neurooncol. 2012, 107, 343-349
26. Ciuffini, L.; Castellani, L.; Salvati, E.; Galletti, S.; Falcone, G.; Alema, S. Delineating v-Src downstream effector pathways in transformed myoblasts Oncogene 2008, 27, 528-539
27. Lin, S. Y.; Lee, W. R.; Su, Y. F.; Hsu, S. P.; Lin, H. C.; Ho, P. Y.; Hou, T. C.; Chou, Y. P.; Kuo, C. T.; Lee, W. S. Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor Angiogenesis 2012, 15, 671-683
28. Hou, T. C.; Lin, J. J.; Wen, H. C.; Chen, L. C.; Hsu, S. P.; Lee, W. S. Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP- signaling pathway Biochem. Pharmacol. 2013, 85, 376-384
29. Piva, R.; Cancelli, I.; Cavalla, P.; Bortolotto, S.; Dominguez, J.; Draetta, G. F.; Schiffer, D. Proteasome-dependent degradation of p27/kip1 in gliomas J. Neuropathol. Exp. Neurol. 1999, 58, 691-696
30. Piva, R.; Cavalla, P.; Bortolotto, S.; Cordera, S.; Richiardi, P.; Schiffer, D. p27/kip1 expression in human astrocytic gliomas Neurosci. Lett. 1997, 234, 127-130
31. Roy, S.; Gu, M.; Ramasamy, K.; Singh, R. P.; Agarwal, C.; Siriwardana, S.; Sclafani, R. A.; Agarwal, R. p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer Cancer Res. 2009, 69, 1166-1173
32. Shankar, S.; Ganapathy, S.; Chen, Q.; Srivastava, R. K. Curcumin sensitizes TRAIL-resistant xenografts: Molecular mechanisms of apoptosis, metastasis and angiogenesis Mol. Cancer 2008, 7, 16